Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222911 · ClinicalTrials.gov registry record · Phase 4
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
A Phase 4 study of Plantar Fasciitis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00222911 is a Phase 4 study of Plantar Fasciitis that has completed, run by University of Pittsburgh. The registered enrollment target is 75 participants, below the 97-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00222911, a Phase 4 study of Plantar Fasciitis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of this study is to examine the combined effect of both dorsiflexion night splints and medial arch supports and compare it to the effect of these interventions each by itself in the treatment of plantar fasciitis.
Conditions Studied
Interventions
- DEVICE dorsiflexion night splint
- DEVICE medial arch support
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222911
The ClinicalTrials.gov registry entry for NCT00222911 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 97-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (23% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plantar Fasciitis appearing as the primary indexed condition, and to 2 interventions - of which dorsiflexion night splint is the first listed.
NCT00222911 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00222911 about?
NCT00222911 is a clinical study titled "Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports". The overall purpose of this study is to examine the combined effect of both dorsiflexion night splints and medial arch supports and compare it to the effect of these interventions each by itself in the treatment of plantar fasciitis.
What is the current status of trial NCT00222911?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2005-08. Estimated completion is 2006-11.
What conditions does trial NCT00222911 study?
This clinical trial studies the following conditions: Plantar Fasciitis.
What interventions are being tested in trial NCT00222911?
The interventions under investigation include: dorsiflexion night splint (DEVICE), medial arch support (DEVICE).
Who is sponsoring clinical trial NCT00222911?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00222911 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fasciitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lateral Plantar Artery Embolization For Plantar Fasciitis
RECRUITING · Phase 1
-
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
RECRUITING · NA
-
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
COMPLETED · Phase 2
-
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
COMPLETED · Phase 3
-
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
COMPLETED · Phase 2
-
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.